US · Healthcare

Interpharm Holdings Inc (IPAH)

Drug Manufacturers - Specialty & Generic

Interpharm Holdings Inc (IPAH) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for IPAH

P/E ratio

18.00

Interpharm Holdings Inc (IPAH) — FAQ

What is IPAH's P/E ratio?

The price-to-earnings (P/E) ratio for Interpharm Holdings Inc (IPAH) is 18.00 (data as of 2026-03-24).

Does Interpharm Holdings Inc pay a dividend?

Dividend yield is not available in the current snapshot for Interpharm Holdings Inc (IPAH). Check the MyAverix Finance app for the latest dividend data.

What sector is Interpharm Holdings Inc in?

Interpharm Holdings Inc (IPAH) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is IPAH listed on?

IPAH is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)